Hepatic glycosphingolipid deficiency and liver function in mice

Recent studies have reported that glycosphingolipids (GSLs) might be involved in obesity-induced insulin resistance. Those reports suggested that inhibition of GSL biosynthesis in animals ameliorated insulin resistance accompanied by improved glycemic control and decreased liver steatosis in obese m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Jennemann, Richard (VerfasserIn) , Rothermel, Ulrike (VerfasserIn) , Wang, Shijun (VerfasserIn) , Sandhoff, Roger (VerfasserIn) , Kaden, Sylvia (VerfasserIn) , Out, Ruud (VerfasserIn) , van Berkel, Theo J. (VerfasserIn) , Aerts, Johannes M. (VerfasserIn) , Ghauharali, Karen (VerfasserIn) , Sticht, Carsten (VerfasserIn) , Gröne, Hermann-Josef (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: [May 2010]
In: Hepatology
Year: 2010, Jahrgang: 51, Heft: 5, Pages: 1799-1809
ISSN:1527-3350
DOI:10.1002/hep.23545
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1002/hep.23545
Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/hep.23545
Volltext
Verfasserangaben:Richard Jennemann, Ulrike Rothermel, Shijun Wang, Roger Sandhoff, Sylvia Kaden, Ruud Out, Theo J. van Berkel, Johannes M. Aerts, Karen Ghauharali, Carsten Sticht, and Hermann-Josef Gröne

MARC

LEADER 00000caa a2200000 c 4500
001 1854219618
003 DE-627
005 20240311130525.0
007 cr uuu---uuuuu
008 230802s2010 xx |||||o 00| ||eng c
024 7 |a 10.1002/hep.23545  |2 doi 
035 |a (DE-627)1854219618 
035 |a (DE-599)KXP1854219618 
035 |a (OCoLC)1425874383 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Jennemann, Richard  |e VerfasserIn  |0 (DE-588)1165151189  |0 (DE-627)1029316392  |0 (DE-576)510266924  |4 aut 
245 1 0 |a Hepatic glycosphingolipid deficiency and liver function in mice  |c Richard Jennemann, Ulrike Rothermel, Shijun Wang, Roger Sandhoff, Sylvia Kaden, Ruud Out, Theo J. van Berkel, Johannes M. Aerts, Karen Ghauharali, Carsten Sticht, and Hermann-Josef Gröne 
264 1 |c [May 2010] 
300 |b Illustrationen 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a First published: 22 April 2010 
500 |a Gesehen am 02.08.2023 
520 |a Recent studies have reported that glycosphingolipids (GSLs) might be involved in obesity-induced insulin resistance. Those reports suggested that inhibition of GSL biosynthesis in animals ameliorated insulin resistance accompanied by improved glycemic control and decreased liver steatosis in obese mice. In addition, pharmacologic GSL depletion altered hepatic secretory function. In those studies, ubiquitously acting inhibitors for GSL biosynthesis have been used to inhibit the enzyme Ugcg (UDP-glucose:ceramide glucosyltransferase), catalyzing the first step of the glucosylceramide-based GSL-synthesis pathway. In the present study a genetic approach for selective GSL deletion in hepatocytes was chosen to achieve complete inhibition of GSL synthesis and to avoid possible adverse effects caused by Ugcg inhibitors. Using the Cre/loxP system under control of the albumin promoter, GSL biosynthesis in hepatocytes and their release into the plasma could be effectively blocked. Deletion of GSL in hepatocytes did not change the quantity of bile excretion through the biliary duct. Total bile salt content in bile, feces, and plasma from mutant mice showed no difference as compared to control animals. Cholesterol concentration in liver, bile, feces, and plasma samples remained unaffected. Lipoprotein concentrations in plasma samples in mutant animals reached similar levels as in their control littermates. No alteration in glucose tolerance after intraperitoneal application of glucose and insulin appeared in mutant animals. A preventive effect of GSL deficiency on development of liver steatosis after a high-fat diet was not observed. Conclusion: The data suggest that GSL in hepatocytes are not essential for sterol, glucose, or lipoprotein metabolism and do not prevent high-fat diet-induced liver steatosis, indicating that Ugcg inhibitors exert their effect on hepatocytes either independently of GSL or mediated by other (liver) cell types. HEPATOLOGY 2010 
700 1 |a Rothermel, Ulrike  |e VerfasserIn  |4 aut 
700 1 |a Wang, Shijun  |d 1963-  |e VerfasserIn  |0 (DE-588)1013188381  |0 (DE-627)704977257  |0 (DE-576)346668077  |4 aut 
700 1 |a Sandhoff, Roger  |e VerfasserIn  |0 (DE-588)1076130577  |0 (DE-627)834454955  |0 (DE-576)181995344  |4 aut 
700 1 |a Kaden, Sylvia  |e VerfasserIn  |4 aut 
700 1 |a Out, Ruud  |e VerfasserIn  |4 aut 
700 1 |a van Berkel, Theo J.  |e VerfasserIn  |4 aut 
700 1 |a Aerts, Johannes M.  |e VerfasserIn  |4 aut 
700 1 |a Ghauharali, Karen  |e VerfasserIn  |4 aut 
700 1 |a Sticht, Carsten  |d 1972-  |e VerfasserIn  |0 (DE-588)1020115718  |0 (DE-627)691110077  |0 (DE-576)250042177  |4 aut 
700 1 |a Gröne, Hermann-Josef  |d 1950-  |e VerfasserIn  |0 (DE-588)1054822697  |0 (DE-627)792339541  |0 (DE-576)170213773  |4 aut 
773 0 8 |i Enthalten in  |t Hepatology  |d [Alphen aan den Rijn] : Wolters Kluwer Health, 1981  |g 51(2010), 5, Seite 1799-1809  |h Online-Ressource  |w (DE-627)268132003  |w (DE-600)1472120-X  |w (DE-576)077450183  |x 1527-3350  |7 nnas  |a Hepatic glycosphingolipid deficiency and liver function in mice 
773 1 8 |g volume:51  |g year:2010  |g number:5  |g pages:1799-1809  |g extent:11  |a Hepatic glycosphingolipid deficiency and liver function in mice 
856 4 0 |u https://doi.org/10.1002/hep.23545  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1002/hep.23545  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230802 
993 |a Article 
994 |a 2010 
998 |g 1054822697  |a Gröne, Hermann-Josef  |m 1054822697:Gröne, Hermann-Josef  |d 50000  |e 50000PG1054822697  |k 0/50000/  |p 11  |y j 
998 |g 1020115718  |a Sticht, Carsten  |m 1020115718:Sticht, Carsten  |d 60000  |d 999811  |e 60000PS1020115718  |e 999811PS1020115718  |k 0/60000/  |k 1/60000/999811/  |p 10 
998 |g 1076130577  |a Sandhoff, Roger  |m 1076130577:Sandhoff, Roger  |d 50000  |e 50000PS1076130577  |k 0/50000/  |p 4 
998 |g 1013188381  |a Wang, Shijun  |m 1013188381:Wang, Shijun  |d 50000  |e 50000PW1013188381  |k 0/50000/  |p 3 
999 |a KXP-PPN1854219618  |e 4362553193 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedKey":"2010","dateIssuedDisp":"[May 2010]"}],"id":{"doi":["10.1002/hep.23545"],"eki":["1854219618"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"person":[{"family":"Jennemann","display":"Jennemann, Richard","given":"Richard","role":"aut"},{"given":"Ulrike","family":"Rothermel","display":"Rothermel, Ulrike","role":"aut"},{"role":"aut","family":"Wang","display":"Wang, Shijun","given":"Shijun"},{"given":"Roger","display":"Sandhoff, Roger","family":"Sandhoff","role":"aut"},{"family":"Kaden","display":"Kaden, Sylvia","given":"Sylvia","role":"aut"},{"role":"aut","display":"Out, Ruud","family":"Out","given":"Ruud"},{"role":"aut","family":"van Berkel","display":"van Berkel, Theo J.","given":"Theo J."},{"role":"aut","given":"Johannes M.","family":"Aerts","display":"Aerts, Johannes M."},{"role":"aut","display":"Ghauharali, Karen","family":"Ghauharali","given":"Karen"},{"given":"Carsten","display":"Sticht, Carsten","family":"Sticht","role":"aut"},{"role":"aut","given":"Hermann-Josef","display":"Gröne, Hermann-Josef","family":"Gröne"}],"title":[{"title_sort":"Hepatic glycosphingolipid deficiency and liver function in mice","title":"Hepatic glycosphingolipid deficiency and liver function in mice"}],"physDesc":[{"extent":"11 S.","noteIll":"Illustrationen"}],"relHost":[{"disp":"Hepatic glycosphingolipid deficiency and liver function in miceHepatology","recId":"268132003","pubHistory":["1.1981 -"],"note":["Gesehen am 28.02.08"],"origin":[{"publisherPlace":"[Alphen aan den Rijn] ; Philadelphia, Pa. ; New York [u.a.]","dateIssuedDisp":"1981-","dateIssuedKey":"1981","publisher":"Wolters Kluwer Health ; Saunders ; Wiley Interscience"}],"id":{"doi":["10.1002/(ISSN)1527-3350"],"eki":["268132003"],"issn":["1527-3350"],"zdb":["1472120-X"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Hepatology","subtitle":"official journal of the American Association for the Study of Liver Diseases","title":"Hepatology"}],"part":{"issue":"5","extent":"11","year":"2010","text":"51(2010), 5, Seite 1799-1809","pages":"1799-1809","volume":"51"}}],"name":{"displayForm":["Richard Jennemann, Ulrike Rothermel, Shijun Wang, Roger Sandhoff, Sylvia Kaden, Ruud Out, Theo J. van Berkel, Johannes M. Aerts, Karen Ghauharali, Carsten Sticht, and Hermann-Josef Gröne"]},"recId":"1854219618","note":["First published: 22 April 2010","Gesehen am 02.08.2023"]} 
SRT |a JENNEMANNRHEPATICGLY2010